Protagonist Therapeutics Inc header image

Protagonist Therapeutics Inc

PTGX

Equity

ISIN US74366E1029 / Valor 33278818

NASDAQ (2024-11-21)
USD 41.65+2.46%

Protagonist Therapeutics Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

Protagonist Therapeutics Inc, known by its Valor number 33278818, is a publicly traded company. The stock of the company is available through the stock provider NASDAQ. As of 21.11.2024, the current price of the stock is USD 41.65. The latest price change for this stock is 2.46%, which reflects the market’s response to various factors such as company performance, industry trends, and global economic conditions. The company has been evaluated by users of Umushroom, and has received a rating of 0 stars.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

140%1Y
18.9%3Y
311%5Y

Performance

49.9%1Y
76.0%3Y
103%5Y

Volatility

Market cap

2423 M

Market cap (USD)

Daily traded volume (Shares)

275,067

Daily traded volume (Shares)

1 day high/low

43.17 / 40.87

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Harmony Biosciences Holdings Inc
Harmony Biosciences Holdings Inc Harmony Biosciences Holdings Inc Valor: 56295735
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.34%USD 33.23
Revance Therapeutics Inc
Revance Therapeutics Inc Revance Therapeutics Inc Valor: 23239569
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.05%USD 3.84
Amylyx Pharmaceuticals Inc
Amylyx Pharmaceuticals Inc Amylyx Pharmaceuticals Inc Valor: 115580129
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.76%USD 5.19
AstraZeneca PLC
AstraZeneca PLC AstraZeneca PLC Valor: 163523
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.68%USD 64.26
Amgen Inc
Amgen Inc Amgen Inc Valor: 907582
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.71%USD 289.90
Sanofi SA
Sanofi SA Sanofi SA Valor: 1447201
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.42%USD 47.98
Biogen Inc
Biogen Inc Biogen Inc Valor: 1720684
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.29%USD 158.01
Illumina Inc
Illumina Inc Illumina Inc Valor: 1111080
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.03%USD 136.99
GE Healthcare Technologies Inc
GE Healthcare Technologies Inc GE Healthcare Technologies Inc Valor: 123735674
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-3.42%USD 82.00
Alnylam Pharmaceuticals Inc
Alnylam Pharmaceuticals Inc Alnylam Pharmaceuticals Inc Valor: 1806798
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.80%USD 246.80